Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30496175 | 0.91 | KDM4E (0.34) | CYP1A2CYP2C9CYP2C19RECQLTSHR | |
| SCHEMBL3267700 | 0.81 | — | — | |
| SCHEMBL28003670 | 0.77 | LMNA (0.33) | — | |
| SCHEMBL1686809 | 0.77 | LMNA (0.33) | — | |
| SCHEMBL1686896 | 0.77 | LMNA (0.33) | — | |
| SCHEMBL1687014 | 0.77 | LMNA (0.33) | — | |
| SCHEMBL1686979 | 0.77 | LMNA (0.33) | — | |
| SCHEMBL1686972 | 0.77 | LMNA (0.33) | — | |
| SCHEMBL1687090 | 0.77 | LMNA (0.33) | — | |
| SCHEMBL1173480 | 0.76 | CES2 (0.33) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12640399-B2 | Localized high salt concentration electrolyte | WILDCAT DISCOVERY TECHNOLOGIES, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260011788-A1 | LOCALIZED HIGH SALT CONCENTRATION ELECTROLYTE | Wildcat discovery technologies inc (US) | 2026-01-08 | — | — | US | disclosed |
| US-20230366590-A1 | METHOD AND SYSTEM FOR RECOVERING AND UTILIZING HEAT ENERGY PRODUCED BY COMPUTER HARDWARE IN BLOCKCHAIN MINING OPERATIONS | G6 MATERIALS CORP. (US) | 2023-11-16 | — | — | US | disclosed |
| US-20220399595-A1 | LIQUID HEAT TRANSFER MIXTURE AND USE THEREOF | ALPRAAZ AB (SE) | 2022-12-15 | — | — | US | disclosed |
| US-20210317283-A1 | AEROGEL MATERIALS AND METHODS FOR THEIR PRODUCTION | AEROGEL TECHNOLOGIES, LLC (US) | 2021-10-14 | — | — | US | disclosed |
| US-20180112054-A1 | AEROGEL MATERIALS AND METHODS FOR THEIR PRODUCTION | AEROGEL TECHNOLOGIES, LLC (US) | 2018-04-26 | — | — | US | disclosed |
| EP-3286264-A1 | AEROGEL MATERIALS AND METHODS FOR THEIR PRODUCTION | Aerogel Technologies, LLC (US) | 2018-02-28 | — | — | EP | disclosed |
| WO-2016161123-A1 | AEROGEL MATERIALS AND METHODS FOR THEIR PRODUCTION | AEROGEL TECHNOLOGIES, LLC (US) | 2016-10-06 | — | — | WO | disclosed |
| EP-2688973-A1 | FLUORINATED OXIRANES AS HEAT TRANSFER FLUIDS | 3M Innovative Properties Company (US) | 2014-01-29 | — | — | EP | disclosed |
| US-8323615-B2 | Methods of processing multi-phasic dispersions | BAXTER INTERNATIONAL INC. (US) | 2012-12-04 | — | — | US | disclosed |
| WO-2012134860-A1 | FLUORINATED OXIRANES AS HEAT TRANSFER FLUIDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-10-04 | — | — | WO | disclosed |
| US-20100047162-A1 | METHODS OF PROCESSING MULTI-PHASIC DISPERSONS | BAXTER INTERNATIONAL INC. (US) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260011788-A1 | LOCALIZED HIGH SALT CONCENTRATION ELECTROLYTE | SLC8A1, NCS1, CACNA1S | CYP1A2 3918/4885CYP2C9 2825/4885CYP2C19 2978/4885 |
| US-12640399-B2 | Localized high salt concentration electrolyte | SLC8A1, SLC6A6, SLC20A1 | CYP1A2 3677/4885CYP2C9 2679/4885CYP2C19 2010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.